Cargando…
Magnetoliposomes containing magnesium ferrite nanoparticles as nanocarriers for the model drug curcumin
Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behaviour, with a maximum magnetization of 16.2 emu g(−1), a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe(2)O(...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6227978/ https://www.ncbi.nlm.nih.gov/pubmed/30473847 http://dx.doi.org/10.1098/rsos.181017 |
Sumario: | Magnesium ferrite nanoparticles, with diameters around 25 nm, were synthesized by coprecipitation method. The magnetic properties indicate a superparamagnetic behaviour, with a maximum magnetization of 16.2 emu g(−1), a coercive field of 22.1 Oe and a blocking temperature of 183.2 K. These MgFe(2)O(4) nanoparticles were used to produce aqueous and solid magnetoliposomes, with sizes below 130 nm. The potential drug curcumin was successfully incorporated in these nanosystems, with high encapsulation efficiencies (above 89%). Interaction by fusion between both types of drug-loaded magnetoliposomes (with or without PEGylation) and models of biological membranes was demonstrated, using FRET or fluorescence quenching assays. These results point to future applications of magnetoliposomes containing MgFe(2)O(4) nanoparticles in cancer therapy, allowing combined magnetic hyperthermia and chemotherapy. |
---|